A phase II, multi-center, single-arm, global study of MEDI4736 monotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)
Clinical Trial Grant
Awarded By
AstraZeneca Pharmaceuticals, LP
Start Date
April 1, 2015
End Date
March 31, 2020
Awarded By
AstraZeneca Pharmaceuticals, LP
Start Date
April 1, 2015
End Date
March 31, 2020